Q: Thoughts on last week's earning? Comfortable to add at this level?
Thanks very much!
Thanks very much!
5i Research Answer:
EPS of 49c beat estimates of 47.9c; revenue of $2.36B beat estimates of $2.29B. EBITDA of $202.7M matched estimates. BMO raised it to 'outperform' and two other brokers raised target prices. The backlog is at a record ($15.6B) and the nuclear division saw 42% growth, and well ahead of forecast with 30% organic growth. The quarter was fine and the outlook we think has improved. Most of its previous 'issues' seem to have been resolved and we would be OK buying.